Enfermedad de Hansen / Hansen's disease
SEMERGEN, Soc. Esp. Med. Rural Gen. (Ed. impr.)
; 36(4): 299-301, abr. 2010. tab, ilus
Article
in Spanish
| IBECS
| ID: ibc-79430
Responsible library:
ES1.1
Localization: BNCS
RESUMEN
La lepra (enfermedad de Hansen) es una enfermedad granulomatosa crónica que afecta a la piel y a los nervios, fundamentalmente, producida por Mycobacterium leprae. Se considera un proceso preerradicado en España, con una prevalencia de 0,1 casos por 10.000 habitantes. Se ha visto un discreto incremento debido al fenómeno de inmigración desde países con mayor prevalencia de este proceso. El tratamiento que se emplea es una combinación de fármacos como rifampicina, dapsona y clofazimina (AU)
ABSTRACT
Leprosy (Hansen's disease) is a chronic granulomatous disease affecting the skin and nerves that is mainly produced by Mycobacterium leprae. It is considered a pre-eradicated condition in Spain, with a prevalence rate of 0.1 cases per 10,000 inhabitants. A slight increase has been observed due to the phenomenon of immigration from countries with higher prevalence of this condition. Current treatments used share a common base made up of several combined drugs, particularly rifampicin, dapsone, and clofazimin (AU)
Search on Google
Collection:
National databases
/
Spain
Health context:
SDG3 - Health and Well-Being
/
Neglected Diseases
Health problem:
Target 3.3: End transmission of communicable diseases
/
Leprosy
/
Neglected Diseases
Database:
IBECS
Main subject:
Drug Combinations
/
Leprosy
Type of study:
Risk factors
Limits:
Humans
Language:
Spanish
Journal:
SEMERGEN, Soc. Esp. Med. Rural Gen. (Ed. impr.)
Year:
2010
Document type:
Article
Institution/Affiliation country:
Complejo Hospitalario Universitario de Badajoz/España
